BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Thomson Reuters Annual Pharmaceutical Factbook Reveals Key Insights into Current Trends

  July 25, 2012

   · 

  4 min read
• Drug Development

  CytRx Corporation Initiates Phase 1b Clinical Trial with Combination of Aldoxorubicin (INNO-206) and Doxorubicin in Patients with Advanced Solid Tumors

  July 25, 2012

   · 

  1 min read
• Biotech Bay

  A.P. Pharma, Inc. to Raise $53.6 Million in Common Stock Offering

  July 25, 2012

   · 

  1 min read
• Business

  Isconova Concludes Partnership With Virbac S.A.

  July 25, 2012

   · 

  1 min read
• Pharm Country

  Secant Medical Receives Frost & Sullivan 2012 Enabling Technology Award

  July 25, 2012

   · 

  1 min read
• Business

  bioTheranostics Adds Chief Commercial Officer & VP of Corporate Development

  July 25, 2012

   · 

  1 min read
• Drug Development

  ImmunoCellular Therapeutics, Ltd Announces Clearance of IND Application for Phase I Study of Company’s Second Vaccine Product Candidate in Recurrent GBM

  July 25, 2012

   · 

  1 min read
• Business

  Molecular Devices, Inc. Forms Scientific Advisory Board

  July 25, 2012

   · 

  3 min read
• Business

  EXACT Sciences Corporation Reports Second-Quarter 2012 Financial Results

  July 25, 2012

   · 

  1 min read
• Business

  Bristol-Myers Squibb Company ’s Second Quarter Highlighted by the Planned Strategic Acquisition of Amylin Pharmaceuticals, Inc. and Important Clinical Data in Immuno-Oncology

  July 25, 2012

   · 

  1 min read